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Abstract
Background and aims—Lipoprotein lipase (LPL) is a candidate gene for obesity based on its 
role in triglyceride hydrolysis and the partitioning of fatty acids towards storage or oxidation. 
Whether dietary fatty acids modify LPL associated obesity risk is unknown.
Methods and results—We examined five single nucleotide polymorphisms (SNPs) (rs320, 
rs2083637, rs17411031, rs13702, rs2197089) for potential interaction with dietary fatty acids for 
obesity traits in 1171 participants (333 men and 838 women, aged 45–75 y) of the Boston Puerto 
Rican Health Study (BPRHS). In women, SNP rs320 interacted with dietary polyunsaturated fatty 
acids (PUFA) for body mass index (BMI) (P = 0.002) and waist circumference (WC) (P = 0.001) 
respectively. Higher intake of PUFA was associated with lower BMI and WC in homozygotes of 
the major allele (TT) (P = 0.01 and 0.005) but not in minor allele carriers (TG and GG). These 
interactions were replicated in an independent population, African American women of the 
Atherosclerosis Risk in Communities (ARIC) study (n = 1334).
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Conclusion—Dietary PUFA modulated the association of LPL rs320 with obesity traits in two 
independent populations. These interactions may be relevant to the dietary management of 
obesity, particularly in women.
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Introduction
Obesity in the US has reached an overall prevalence of nearly 34% [1], with greater 
prevalence in some ethnic minorities [2], which might be related to differences in genetic 
background and behavioral factors [3–5]. The investigation of genetic variants for obesity in 
conjunction with behavioral factors, especially diet, may benefit development of more 
specific strategies to ameliorate susceptibility to weight gain.
Lipoprotein lipase (LPL) is a candidate gene for obesity, based on its encoded function to 
absorb fatty acids across tissues [6,7]. LPL contributes to fat storage in adipocytes [8], 
regulation of thermogenesis in skeletal muscle [9]. However, in spite of LPL’s demonstrated 
role in obesity, relevant association studies with LPL single nucleotide polymorphism (SNP) 
have inconsistent findings and show sex-specific differences [10,11].
One hypothesis that may account for the inconsistency is that unexamined factors may 
modulate LPL-associated obesity risk. Dietary fat type (e.g., saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA)) have been 
evaluated for obesity risk independently of genotype for decades [4]. However, it remains to 
be explored whether intakes of different fatty acids alter obesity-related traits in the context 
of LPL genotype.
Therefore, we aimed to determine whether dietary fatty acids interact with LPL variants for 
obesity traits in a population of multiple ancestries, stratified by sex. We also aimed to 
replicate our findings in an independent population.
Methods
Study populations
Discovery population: The Boston Puerto Rican Health Study (BPRHS)—In the 
BPRHS, there were 1171 participants of Puerto Rican origin, aged 45–75 years, living in the 
Greater Boston, MA metropolitan area, after excluding those with missing data and 
implausible energy intake, defined as <2512 kJ (600 kcal) per day or >20093 kJ (4800 kcal) 
per day. Details for the study have been described previously [12]. Fasting blood were 
collected for biochemical and genetic analyses. Anthropometric methods were consistent 
with techniques used by the National Health and Nutrition Examination Surveys. The study 
protocol was approved by the Institutional Review Board at Tufts Medical Center and Tufts 
University Health Sciences Campus. Informed consent was received by all participants or 
their representatives.
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Replication population: Atherosclerosis Risk in Communities Study (ARIC)—
Participants of replication study in ARIC included 2186 African American (AA) and 8689 
European American (EA), considering the multiple ancestry nature of the BPRHS. ARIC 
was a multi-center study with participants aged 44–66 years from Forsyth County, North 
Carolina; Jackson, Mississippi; suburban areas of Minneapolis, Minnesota; and Washington 
County, Maryland [13]. Individuals with implausible energy intakes, defined as in the 
BPRHS, were excluded from analysis. Body weight was measured using a calibrated scale 
with subjects in scrub suits without shoes and height was measured using a ruler. Waist 
circumference (WC) at the umbilicus was measured using a tape measure. Fasting blood was 
collected from an antecubital vein into a vacuum tube with ethylenediamine tetraacetic acid. 
Triglycerides and high-density lipoprotein (HDL) were assayed using enzymatic methods 
and dextran-magnesium precipitation respectively [14]. This study was approved by the 
Institutional Review Board at each field center, and the University of North Carolina at 
Chapel Hill. Informed consent was received by all participants or their representatives.
SNP selection, genotyping and linkage disequilibrium (LD) analysis
Four lipids related SNPs (rs2083637, rs17411031, rs13702, and rs2197089) [15–17], and 
rs320 (common name as HindIII ) with inconsistent associations with obesity [10,11] were 
selected as discovery panel tested in BPRHS. Genotyping in BPRHS was performed using 
the ABI TaqMan SNP genotyping system 7900HT (Applied Biosystems, Foster City, CA). 
Hardy–Weinberg equilibrium (HWE) was evaluated by Chi-square tests. LD and haplotype 
was analyzed by HaploView4.2 [18] according to 1000 Genomes Project. Genotypes of 
replication SNP rs327 in ARIC was imputed by MACH (v1.0.16) [19] with HapMap r22 
reference populations, Utah residents with Northern and Western European Ancestry (CEU) 
and Yoruba in Ibadan, Nigeria (YRI) based on the genome-wide SNP data obtained by the 
Affymetrix 6.0 chip (Affymetrix, Santa Clara, CA).
Dietary assessment
The BPRHS used a semi-quantitative food frequency questionnaire (FFQ) [20]. The ARIC 
study used a modified 66-item interviewer-administered FFQ [21]. Dietary fatty acids intake 
was expressed as a percentage of total energy intake.
Population ancestry admixture
The population admixture of participants in the BPRHS was estimated with reference to 
three ancestral populations including Native American (15%), Southern European (57%), 
and West African (27%), and the major principal component estimated by EIGENSTRAT 
was adjusted in the analysis [22]. The first 10 principal components, estimated using 
Eigensoft, represent admixture for ARIC EAs. Percentage of European ancestry for ARIC 
AAs was estimated based on the reference population of CEU using 1350 ancestry 
informative markers by ANCESTRYMAP [23].
Statistical analysis
Analysis of covariance and general linear models were applied to test genetic associations 
and interactions between SNPs and different types of dietary fat intake (SFA, MUFA and 
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PUFA) to modulate body mass index (BMI) and WC, assuming an additive genetic model 
and adjusting age, admixture, smoking, drinking, total fat intake (interaction test), total 
energy intake, antilipemic medication, diabetes status, hormone replacement therapy 
(inwomen), physical activity, and education. Dietary fat intake was analyzed as both 
continuous and categorical variables, dichotomized by the population median, for validation. 
Log transformation was performed when necessary. Data were analyzed using SAS 9.2 
(SAS Institute, Inc. Cary, NC). A two-tailed P-value of <0.02 was considered statistically 
significant, adjusting for three multiple tests introduced by three SNPs reaching HWE. 
Successful replication was considered when the analysis with the same additive model and 
covariates resulted in the significant interactions in the same direction across different 
populations. Inverse-variance weighted fixed-effects meta-analyses were conducted using 
METAL (University of Michigan; www.sph.umich.edu/csg/abecasis/metal/) to summarize 
the interactions across populations.
Bioinformatics analysis
Sequences surrounding the candidate SNP with significant interactions were screened via 
NUBIScan [24], a software evaluated peroxisome proliferator-activated receptors response 
elements (PPREs), for which fatty acids (especially PUFAs) are the primary ligand.
Results
Population characteristics
Demographic data, anthropometrics, lipids, nutrient intakes, disease status and medication 
use for both the BPRHS and ARIC are presented by sex (Table 1). Women in the BPRHS 
and in ARIC AAs were characterized for obesity status, using the cutoff of BMI ≥30 kg/m2 
for obesity and cutoff of WC ≥ 88 cm in women for abdominal obesity. Dietary PUFA 
contributed 8.5% of energy intake in the BPRHS and 5% in ARIC, and it was similar for 
men and women within each cohort.
Discovery in BPRHS
Minor allele frequencies (MAF) were greater than 0.25 (Table 2). Rs2083637 and 
rs17411031 deviated from HWE (P = 0.03 and P = 0.02) and thus were excluded in the 
following analysis.
Rs320, rs13702, and rs2197089 were not associated with BMI and WC (Supplementary 
Table 1). Both categorical PUFA (Supplementary Table 2) and continuous PUFA (Fig. 1) 
showed significant interaction with rs320 for BMI (P = 0.02 and P = 0.002, respectively) 
and WC (P = 0.02 and P = 0.001, respectively). In homozygotes of the major allele (TT), 
higher PUFA intake associated with lower BMI (P = 0.01) and smaller WC (P = 0.005) 
(Fig. 1). However, in carriers of minor allele (TG and GG), there were no associations (P > 
0.1) (Fig. 1). Significance and interaction pattern were similar for N6- and N3-PUFA 
(Supplementary Table 2). Results remained the same after excluding women (n = 22) using 
hormone replacement (Data not shown). No significant interactions were observed in men 
(Fig. 1 and Supplementary Table 2), for SFA or MUFA, or with rs13702 or rs2197089 (data 
not shown). Data reported below apply to the single SNP rs320.
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Rs327 was selected for replication in ARIC because of its close distance to rs320 (459 bp), 
the high imputation quality (R2 = 1), and its strong LD with rs320 in CEU, African ancestry 
in the Southwest USA (ASW), and Mexican ancestry in Los Angeles (MXL) populations in 
the 1000 Genomes Project (R2 > 0.8) (Fig. 2).
Interaction with continuous PUFA in AA women was significant for WC (P = 0.01) and 
approached significance for BMI (P = 0.07). Interactions were not significant in AA men or 
EAs (Fig. 2), and similar results were with categorical PUFA (Supplementary Fig. 1).
In a meta-analysis of the women from all three populations, rs320/rs327 showed significant 
interaction with continuous PUFA intake for both BMI (P = 0.009) and WC (P = 0.003) 
(Fig. 2). However, interaction P values were even lower when the meta-analysis included 
only two women population, BPRHS and ARIC AAs (P = 0.001 for BMI and P = 4 × 10−5 
for WC). The betas for the interaction term were consistently negative in three populations. 
There were no interactions in men (Fig. 2). Analysis with categorical PUFA exhibited 
similar results (Supplementary Fig. 1).
Bioinformatics analysis
There was a PPRE approximately 14 kb downstream of rs320 (Fig. 3).
Discussion
In the current study, we identified and replicated significant interactions between dietary 
PUFA intake and LPL rs320 for obesity traits in women. In the homozygosity for the major 
allele (TT), increase in PUFA intake associated with lower BMI and WC. Our observed 
gene–diet interaction may have improved our ability to detect dietary effects that are 
apparent only under certain genotype.
Genetic modulation of dietary associations has been suggested by the studies for plasma 
lipids [25,26]. TT group showed greater improvement in plasma lipids with calorie 
restriction intervention [25]. Our group also found that TT genotype had a greater 
postprandial lipidemia response following an oral fat load [26]. These may suggest that T-
carriers are more responsive to diet than G-carriers, which is consistent with our findings for 
PUFA intake. Considering the existence of the PPRE near rs320, we hypothesize that the 
apparently greater responsiveness of T allele to PUFA may involve the higher binding 
affinity to the transcription factor of this allele compared to G allele [27]. The anti-obesity 
effects of PUFA found are consistent with previous studies [28], which may be related to 
decreased adipocyte LPL activity [29], reduced triglyceride storage and less fat deposition.
Our sex-specific finding is consistent with previous study [7], and may be due to the sex-
specific LPL response. LPL expression in muscle was 160% higher in women than men [6]. 
Our finding of null genetic association with obesity is consistent with a US study [11] not a 
French one [10], which may further support our hypothesis of gene–diet interaction due to 
potential differences in dietary pattern.
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Limitations include the cross-sectional design and the absence of adipose LPL expression 
measurement. The variable ancestral admixtures and high prevalence of obesity in both 
minority populations (BPRHS and ARIC AAs) restricted our study from drawing 
conclusions about the relative contributions of genetic background, behavioral and socio-
economic factors to the observed interactions. As our results are preliminary, additional 
studies are desirable.
In summary, we detected a significant interaction between LPL rs320 and dietary PUFA for 
obesity-related outcomes in women, and these findings were strengthened by replication in a 
second, independent population. Our observations may be relevant to the nutritional 
management of obesity in women.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Discovery of continuous interaction between rs320 and dietary PUFA intake for obesity 
traits in the BPRHS, by sex
Predicted BMI (A for women, B for men) and WC (C for women, D for men) by rs320 
genotype were plotted against continuous dietary PUFA adjusted for age, admixture, 
smoking, drinking, total energy intake, total fat intake, diabetes status, antilipemic 
medication, hormone replacement therapy in women, physical activity, and education. P 
values indicate the statistical significance of the adjusted interaction term and adjusted 
regression coefficients in the regression line corresponding to three genotype groups of 
rs320 (TT, TG, and GG).
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Figure 2. Replication and meta-analysis of continuous interaction between rs320/rs327 and 
dietary PUFA intake for obesity traits by sex
LD correlation (100 × R2 value in diamond), haplotypes and corresponding frequencies of 
rs320 and replication SNP rs327 in 1000 Genomes CEU (A), ASW (B) and MXL (C) are 
presented. Forest plots of this continuous interactions modulating BMI (left) and WC (right) 
in women (D) and men (E) are presented. The estimates represent the difference in the 
magnitude of the PUFA association (per +1-unit intake of PUFA) with BMI or WC per copy 
of the T allele of rs320/rs327, adjusting for age, admixture, smoking, drinking, total energy 
intake, total fat intake, diabetes status, antilipemic medication, hormone replacement therapy 
in women, physical activity, and education. Filled square and horizontal line represent the 
estimate and 95% CI for each population, and the filled diamond represent the summary 
estimate and its 95% CI.
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Figure 3. Genomic structure of LPL locus
The gene is transcribed as indicated by the large horizontal arrow. Exons are the larger 
rectangular black boxes.
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Table 1
Participant characteristics in the BPRHS and ARIC, by sex.a
Discovery Replication














 Age, year 57 (8) 58 (7) 53.92 (6) 53.2 (6) 54.66 (6) 53.9 (6)
 Current smoker, n 111 (33%) 172 (21%) 310 (36%) 335 (25%) 1009 (24%) 1142 (25%)
 Current drinker, n 158 (47%) 290 (35%) 423(50%) 280 (21%) 2961 (71%) 2818 (62%)
Anthropometric measures
 BMI, kg/m2 29.6 (5.1) 32.9 (7.0) 28 (4.8) 30.7 (6.6) 27.4 (4.0) 26.5 (5.4)
 WC, cm 102 (15) 102 (16) 98 (13) 100 (16) 100 (10) 93 (15)
Lipids
 Triglycerides, mmol/l 1.66 (1.77) 1.55 (1.63) 1.4 (1.25) 1.24 (0.74) 1.66 (1.13) 1.45 (0.93)
 Total cholesterol, mmol/l 4.47 (1.14) 4.87 (1.05) 5.47 (1.11) 5.62 (1.16) 5.45 (0.99) 5.64 (1.1)
 HDL cholesterol, mmol/l 1.03 (0.31) 1.21 (0.31) 1.29 (0.42) 1.5 (0.44) 1.11 (0.32) 1.49 (0.44)
 LDL cholesterol, mmol/l 2.57 (0.91) 2.86 (0.89) 3.57 (1.06) 3.57 (1.13) 3.61 (0.91) 3.49 (1.02)
Dietary Intake
 Total energy, kcal/d 2483 (883) 2044 (875) 1732 (657) 1514 (569) 1799 (652) 1515 (522)
 Carbohydrate, % total energy/d 48.9 (7.5) 51.5 (7.7) 48.5 (9.1) 50.5 (9.6) 47.3 (9.1) 49.5 (9.3)
 Protein, % total energy/d 16.8 (2.9) 17.2 (3.5) 17.2 (3.9) 18.7 (4.5) 17.1 (3.7) 18.5 (4.2)
 Total fat, % total energy/d 32.9 (5.7) 31.7 (5.5) 32.0 (6.3) 32.1 (6.5) 33.6 (6.8) 32.8 (6.8)
 SFA, % total energy/d 10.1 (2.5) 9.6 (2.3) 11.4 (2.7) 11.4 (2.7) 12.4 (3.0) 12.1 (3.1)
 MUFA, % total energy/d 11.4 (2.1) 11.0 (2.1) 12.6 (2.8) 12.5 (2.9) 13.0 (3.0) 12.4 (3.0)
 PUFA, % total energy/d 8.6 (2.0) 8.5 (2.0) 4.7 (1.2) 4.9 (1.3) 5.1 (1.5) 5.1 (1.5)
 Cholesterol, mg/d 377 (191) 283 (162) 312 (162) 250 (124) 269 (139) 223 (104)
Disease and medication
 Have diabetes, n 137 (41%) 331 (40%) 156 (18%) 256 (19%) 405 (10%) 334 (7%)
 Take antilipemic medication, n 133 (40%) 343 (41%) 6 (1%) 7 (1%) 84 (2%) 87 (2%)
 Take anti-depressants, n 84 (25%) 323 (39%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Take hormone replacement
 therapy in women, n
0 (0%) 22 (3%) 0 (0%) 211(16%) 0 (0%) 984 (22%)
a
Data are means (standard deviation) or n (%).
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Table 2
Minor allele frequency (MAF) of LPL SNPs in the BPRHS.a
Men Women P b























P: P value for HWE testing.
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